Extensive Pathway Oriented Candidate Gene Approach Allows Identification of Factors Influencing CYP3A4 Expression and Function Kathrin Klein, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology;
Maria Thomas, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology;
Stefan Winter, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology;
Thomas Weiss, University of Regensburg;
Matthias Schwab, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology;
Ulrich M. Zanger, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology
Functional assessment of CNV's in human liver Roman Tremmel, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology;
Kathrin Klein, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology;
Stefan Winter, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology;
Matthias Schwab, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology;
Ulrich M. Zanger, Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology